Premium
Cell therapies for treatment of human immunodeficiency virus infection
Author(s) -
Focosi Daniele,
Maggi Fabrizio,
CeccheriniNelli Luca,
Pistello Mauro
Publication year - 2015
Publication title -
reviews in medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.06
H-Index - 90
eISSN - 1099-1654
pISSN - 1052-9276
DOI - 10.1002/rmv.1831
Subject(s) - human immunodeficiency virus (hiv) , transplantation , medicine , induced pluripotent stem cell , virology , immunology , cell therapy , stem cell , biology , embryonic stem cell , biochemistry , genetics , gene
Summary After the serendipitous discovery of HIV eradication in the “Berlin patient”, interest has grown in curing HIV infection by replacing the patient's replication‐competent blood cells with infection‐resistant ones. At the same time, induced pluripotent stem cell technologies and genetic engineering have boosted cell therapy transfer into the clinic. Currently available cell therapy approaches to attempt to cure HIV infection include the following: (1) Transplantation of autologous or allogeneic cells spontaneously resistant or edited to resist HIV infection; (2) Transplantation of autologous T‐lymphocytes spontaneously targeting or redirected against HIV; and (3) Transplantation of autologous cells engineered to work as anti‐HIV antibody factories. We review here the preliminary results and potential for future applications of these approaches. Copyright © 2015 John Wiley & Sons, Ltd.